The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

FDA Guidance for Industry: Alternate Source of the Active Pharmaceutical Ingredient in Pending ANDAs (Posted 12/12/2000)


Freedom of Information Staff, (HFI 35), Food and Drug Administration, Rm. 12 A - 30, 5600 Fishers Lane, Rockville, MD 20857, USA, ,

This guidance is intended to descibe the Office of Generic Drugs' policy on the use of alternate sources of APIs in unapproved abbreviated ANDAs

Go back

GMP Conferences by Topics